CPG for Eating Disorders

SUMMARY OF THE EVIDENCE FORPHARMACOLOGICAL TREATMENT(QUESTIONS 9.9. to 9.15.)SRSE 311++Dropout rates in the RCT assessing pharmacological treatments ranged from0% to 51% of treated cases. No drug in particular showed a greater relapse ratethan others.Anorexia nervosaSRSE 311++The literature relating to medication in AN is scarce and inconclusive.Binge-Eating DisorderSRSE 311++There is moderate evidence that supports the role of drugs in the treatment of BED.GENERAL RECOMMENDATIONS FOR THEPHARMACOLOGICAL TREATMENT OF EATINGDISORDERS(QUESTIONS 9.9. to 9.15.)Anorexia nervosaD 9.GPH.1. Pharmacological treatment is not recommended as the only primarytreatment in patients with AN. (Adopted from recommendation 6.3.6.1. ofthe NICE guide).D 9.GPH.2. Caution should be exercised when prescribing pharmacological treatmentfor patients with AN who have associated comorbidities such as obsessivecompulsivedisorder (OCD) or depression. (Adopted fromrecommendation 6.3.6.2. of the NICE guide).D 9.GPH.3. Given the risk of heart complications presented by patients with AN,prescription of drugs whose side effects may affect cardiac function mustbe avoided. (Adopted from recommendation 6.3.6.4. of the NICE guide).CLINICAL PRACTICE GUIDELINE FOR EATING DISORDERS158